MediFind

Find a Doctor

Takashi Nakano

Gunma University Graduate School Of Medicine
Male

Bio


Takashi Nakano is in Maebashi, Japan. They have been an author on 735 peer reviewed articles in the past 15 years. Dr. Nakano's top three areas of expertise are Malignant Mesothelioma, Metastatic Pleural Tumor, and Lung Cancer.

Contact

Maebashi, JP

Latest Research


Latest Advance
Study
  • Condition: Locally Advanced Hepatocellular Carcinoma (LAHCC)
  • Journal: Radiation oncology (London, England)
  • Treatment Used: Hypofractionated Carbon Ion Radiotherapy (C-ion RT)
  • Number of Patients: 11
  • Published —
This study evaluated the effects of carbon ion radiotherapy (C-ion RT) in patients with locally advanced hepatocellular carcinoma (liver cancer; LAHCC).
Latest Advance
Study
  • Condition: Prostate Cancer
  • Journal: BMC cancer
  • Treatment Used: Carbon Ion Radiotherapy
  • Number of Patients: 304
  • Published —
In this study, researchers evaluated the effectiveness and safety of using carbon ion radiotherapy to treat prostate cancer.
Latest Advance
Study
  • Condition: Cervical Cancer
  • Journal: Cancer medicine
  • Treatment Used: Weekly Cisplatin During Carbon-ion Radiotherapy
  • Number of Patients: 52
  • Published —
In this study, researchers evaluated the long-term effects of weekly cisplatin during carbon-ion radiotherapy for the treatment of cervical cancer.
Latest Advance
Study
  • Condition: Head and Neck Mucosal Melanoma
  • Journal: Cancer medicine
  • Treatment Used: Carbon-Ion Radiotherapy combined with Chemotherapy
  • Number of Patients: 21
  • Published —
This study tested the safety and efficacy of using carbon-ion radiotherapy combined with chemotherapy to treat patients with head and neck mucosal melanoma.
Latest Advance
Study
  • Condition: Stage I Peripheral Nonsmall Cell Lung Cancer (NSCLC)
  • Journal: Cancer medicine
  • Treatment Used: Hypofractionated Carbon-Ion Radiotherapy
  • Number of Patients: 37
  • Published —
This study confirmed the effectiveness and safety of hypofractionated carbon-ion radiotherapy in patients with stage I peripheral nonsmall cell lung cancer (NSCLC).
Latest Advance
Study
  • Condition: Elderly patients with cervical cancer
  • Journal: Brachytherapy
  • Treatment Used: CT-based brachytherapy
  • Number of Patients: 105
  • Published —
The study aims to understand the effect of CT-based brachytherapy (using a CT to guide high doses of radiation to a specific site, reducing the radiation reaching healthy tissue) for elderly patients with cervical cancer.
Latest Advance
Study
  • Condition: Hepatocellular Carcinoma
  • Journal: Radiation oncology (London, England)
  • Treatment Used: Carbon Ion Radiotherapy vs. Transarterial Chemoembolization
  • Number of Patients: 477
  • Published —
This study compared the outcomes of carbon ion radiotherapy versus transarterial chemoemboliation in the treatment of patients with hepatocellular carcinoma.
Latest Advance
Study
  • Condition: Parotid Gland Carcinoma
  • Journal: The Journal of laryngology and otology
  • Treatment Used: Adjuvant Radiation Therapy
  • Number of Patients: 108
  • Published —
This study reviewed the treatment of patients with parotid gland carcinoma.
Latest Advance
Study
  • Condition: Locally Advanced Cervical Cancer
  • Journal: International journal of radiation oncology, biology, physics
  • Treatment Used: Cisplatin
  • Number of Patients: 95
  • Published —
In this study, researchers evaluated the safety and effectiveness of prophylactic extended-field concurrent chemoradiation therapy using weekly cisplatin for patients with locally advanced cervical cancer.
Latest Advance
Study
  • Condition: Chemotherapy-Naive Patients with Advanced Malignant Pleural Mesothelioma
  • Journal: The Lancet. Respiratory medicine
  • Treatment Used: Nintedanib in Combination with Pemetrexed and Cisplatin
  • Number of Patients: 541
  • Published —
This study investigated the effectiveness and safety of pemetrexed plus cisplatin combined with nintedanib or placebo in unresectable malignant pleural mesothelioma.
Latest Advance
Study
  • Condition: Cervical Esophageal Cancer
  • Journal: Cancer chemotherapy and pharmacology
  • Treatment Used: Docetaxel, Cisplatin, and 5-fluorouracil Combination Chemoradiotherapy
  • Number of Patients: 21
  • Published —
In this study, researchers evaluated the effectiveness of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for the treatment of cervical esophageal cancer.
Latest Advance
Study
  • Condition: Locally Advanced Uterine Cervical Squamous Cell Carcinoma
  • Journal: International journal of radiation oncology, biology, physics
  • Treatment Used: Carbon Ion Radiation Therapy with Concurrent Chemotherapy
  • Number of Patients: 22
  • Published —
The purpose of the study was to evaluate the safety and effectiveness of carbon-ion radiation therapy concurrent chemotherapy for locally advanced uterine cervical squamous cell carcinoma.
Latest Advance
Study
  • Condition: Merlin-Stratified Pleural Mesothelioma
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Treatment Used: Defactinib After First-Line Chemotherapy
  • Number of Patients: 344
  • Published —
The study researched the safety and effectiveness of Defactinib after first-line chemotherapy for patients with merlin-stratified pleural mesothelioma.
Latest Advance
Study
  • Condition: Non-squamous cell malignant tumors of the nasopharynx
  • Journal: Cancer medicine
  • Treatment Used: Carbon-ion radiotherapy
  • Number of Patients: 29
  • Published —
The study researched the outcomes of carbon-ion radiotherapy for treating non-squamous cell malignant tumors of the nasopharynx.
Latest Advance
Study
  • Condition: Locally Recurrent Rectal Cancer
  • Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • Treatment Used: Carbon-Ion Radiotherapy
  • Number of Patients: 224
  • Published —
This study tested the safety and efficacy of using carbon-ion radiotherapy to treat patients with locally recurrent rectal cancer.
Latest Advance
Study
  • Condition: Hepatocellular carcinoma
  • Journal: Liver international : official journal of the International Association for the Study of the Liver
  • Treatment Used: Short-course carbon-ion radiation therapy
  • Number of Patients: 174
  • Published —
This study evaluated the effectiveness and safety of short-course carbon-ion radiation therapy for hepatocellular carcinoma.
Latest Advance
Study
  • Condition: Locally Advanced Sinonasal Malignant Tumors
  • Journal: International journal of radiation oncology, biology, physics
  • Treatment Used: carbon-ion radiation therapy
  • Number of Patients: 458
  • Published —
The purpose of the study was to evaluate the safety and effectiveness of carbon-ion radiation therapy for locally advanced sinonasal malignant tumors.
Latest Advance
Study
  • Condition: Pancreatic cancer
  • Journal: International journal of radiation oncology, biology, physics
  • Treatment Used: Carbon-ion radiotherapy
  • Number of Patients: 72
  • Published —
This study evaluated the efficacy and safety of carbon-ion radiotherapy for locally advanced pancreatic cancer.
Latest Advance
Study
  • Condition: Adenoid Cystic Carcinoma (ACC) of the Head and Neck
  • Journal: International journal of radiation oncology, biology, physics
  • Treatment Used: Carbon-Ion Radiation Therapy
  • Number of Patients: 289
  • Published —
This study analyzed the treatment outcomes of carbon-ion radiation therapy for adenoid cystic carcinoma (ACC) of the head and neck at 4 active carbon-ion facilities in Japan.
Latest Advance
Study
  • Condition: Advanced uterine cervical adenocarcinoma
  • Journal: Cancer medicine
  • Treatment Used: Carbon ion radiotherapy plus current radiotherapy
  • Number of Patients: 33
  • Published —
This phase 1/2 study evaluated the efficacy and safety of carbon ion radiotherapy (C-ion RT) with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Maebashi, JP

Insurance

Contact them to find out if they accept your insurance plan.